Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000175

Chief Scientific Officer acquired 13,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kishimoto Takashi Kei Chief Scientific Officer 2021-12-08 Grant or award +13,750 204,139 D
Loading xslF345X03/wf-form4_163917402992018.xml…